心脏毒性

Cardiotoxicity is a significant concern in cancer chemotherapy, as it can cause heart damage in patients.
心脏毒性在癌症化疗中是一个重要问题，因为它可能导致患者心脏损伤。
Early detection and management of cardiotoxicity are crucial to minimize its long-term effects on cardiac function.
早期发现和处理心脏毒性对于减少其对心脏功能的长期影响至关重要。
Some medications used for hypertension can exhibit mild to severe cardiotoxicity if not monitored properly.
一些用于高血压的药物如果管理不当，可能会表现出轻度到重度的心脏毒性。
The patient's symptoms of chest pain were attributed to the cardiotoxicity of their new medication.
患者的胸痛症状被归因于他们新药的心脏毒性。
After undergoing chemotherapy, the survivor experienced mild cardiotoxicity, which resolved with supportive care.
化疗后，幸存者出现了轻微的心脏毒性，但通过支持性护理得以恢复。
Cardiotoxicity is a potential side effect of certain immunotherapy treatments, especially in those with pre-existing heart conditions.
心脏毒性是某些免疫疗法的潜在副作用，特别是对于有既往心脏病史的患者。
Researchers are investigating novel strategies to prevent or mitigate cardiotoxicity in cancer patients.
研究人员正在研究预防或减轻癌症患者心脏毒性的新策略。
Regular cardiac monitoring is essential for patients receiving drugs known to have a high risk of cardiotoxicity.
对于已知具有高心脏毒性风险的药物使用者，定期心脏监测至关重要。
Cardiotoxicity is a concern among athletes who use performance-enhancing drugs, as they can strain the heart.
对于使用性能增强药物的运动员，心脏毒性是一个问题，因为这可能给心脏带来压力。
In some cases, discontinuing the toxic drug may be the most effective way to treat acute cardiotoxicity.
在某些情况下，停止使用有毒药物可能是治疗急性心脏毒性的最有效方法。